Optimal periodic control of a drug delivery system

Abstract Administration of certain drugs at a steady rate results in deterioration of drug effect, also known as drug tolerance. Periodic delivery is an attractive option for minimizing tolerance and maximizing the desired effect of such drugs. In this paper, periodic drug infusion strategies for maximizing a time-averaged measure of drug effect are investigated. A simple pharmacokinetic–pharmacodynamic (PKPD) model of a system exhibiting tolerance is considered and optimal periodic control theory is employed. First, regions of PKPD parameter space in which periodic infusion provides a locally improved average effect compared to steady infusion are characterized using the so-called π -test. Then, optimal drug delivery strategies, obtained using two different computational approaches, are presented for a representative set of parameter values, and insight is provided into the results. The first method, proposed by the authors, is based on the notion of differential flatness, while the second is based on a standard shooting method for dynamic optimization problems.

[1]  John Anthony Bauer,et al.  Application of Pharmacodynamic Modeling for Designing Time-Variant Dosing Regimens to Overcome Nitroglycerin Tolerance in Experimental Heart Failure , 1997, Pharmaceutical Research.

[2]  A. Zhabotinsky,et al.  Mathematical model of cancer chemotherapy. periodic schedules of phase-specific cytotoxic-agent administration increasing the selectivty of therapy , 1985 .

[3]  M. Fliess,et al.  Flatness and defect of non-linear systems: introductory theory and examples , 1995 .

[4]  Martin Guay,et al.  Constrained Optimization of Nonlinear, Dynamic Chemical Processes – A Normalized Form Approach , 2000 .

[5]  A. Goldbeter,et al.  Frequency specificity in intercellular communication. Influence of patterns of periodic signaling on target cell responsiveness. , 1989, Biophysical journal.

[6]  Wolfgang Marquardt,et al.  Dynamic Optimization Based on Higher Order Differential Model Representations , 2000 .

[7]  J. Parker,et al.  Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. , 1995, Circulation.

[8]  W. Jusko,et al.  Role of dosage regimen in controlling indirect pharmacodynamic responses. , 1998, Advanced drug delivery reviews.

[9]  W. Crowley,et al.  Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. , 1986, Endocrine reviews.

[10]  R. Siegel,et al.  Autonomous gel/enzyme oscillator fueled by glucose: Preliminary evidence for oscillations. , 1999, Chaos.

[11]  C. Grimbergen,et al.  An approach to the modeling of the tolerance mechanism in the drug effect. II: On the implications of compensatory regulation. , 1988, Journal of theoretical biology.

[12]  R. Murray,et al.  Flat systems, equivalence and trajectory generation , 2003 .

[13]  M. K. Sunbareshan,et al.  Optimal control in cancer therapy by simultaneous consideration of normal and cancer cell proliferation kinetics , 1984 .

[14]  Lewis B. Sheiner,et al.  Use of a Pharmacokinetic/Pharmacodynamic Model to Design an Optimal Dose Input Profile , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  E. Ekblad,et al.  A model eliciting transient responses. , 1984, The American journal of physiology.

[16]  L B Sheiner,et al.  Pharmacodynamic model of tolerance: application to nicotine. , 1988, The Journal of pharmacology and experimental therapeutics.

[17]  Helmut Maurer,et al.  Solution techniques for periodic control problems : A case study in production planning , 1998 .

[18]  Francis J. Doyle,et al.  A Flatness Based Approach to Optimization in Fed-Batch Bioreactors , 2000 .

[19]  A. Goldbeter,et al.  Frequency specificity in intercellular communication , 2005 .

[20]  Suneel K. Gupta,et al.  Single‐ and Multiple‐Dose Pharmacokinetics of an Oral Once‐a‐Day Osmotic Controlled‐Release OROS® (methylphenidate HC1) Formulation , 2000, Journal of clinical pharmacology.

[21]  R S Parker,et al.  Control-relevant modeling in drug delivery. , 2001, Advanced drug delivery reviews.

[22]  S. Bittanti,et al.  Optimal periodic control and periodic systems analysis: An overview , 1986, 1986 25th IEEE Conference on Decision and Control.

[23]  R. Tallarida,et al.  The concept of a changing receptor concentration: implications for the theory of drug action. , 1985, Journal of theoretical biology.

[24]  R. Murray,et al.  Flat Systems , 1997 .

[25]  C. Grimbergen,et al.  An approach to the modeling of the tolerance mechanism in the drug effect. I: The drug effect as a disturbance of regulations. , 1987, Journal of theoretical biology.

[26]  R. Murray,et al.  Differential Flatness and Absolute Equivalence of Nonlinear Control Systems , 1998 .

[27]  Dennis S. Bernstein,et al.  Optimal periodic control: The π test revisited , 1980 .

[28]  H. Fung,et al.  Pharmacodynamics of in Vivo Nitroglycerin Tolerance in Normal Conscious Rats: Effects of Dose and Dosing Protocol , 2004, Pharmaceutical Research.

[29]  Sergio Bittanti,et al.  Periodic control: A frequency domain approach , 1973 .

[30]  Prodromos Daoutidis,et al.  Numerical solution of the optimal periodic control problem using differential flatness , 2004, IEEE Transactions on Automatic Control.